ABBOTINDIA Stock Overview
Abbott India Limited operates as a pharmaceutical company in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for ABBOTINDIA from our risk checks.
Abbott India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹25,674.45 |
| 52 Week High | ₹29,638.95 |
| 52 Week Low | ₹20,605.05 |
| Beta | 0.057 |
| 1 Month Change | -3.84% |
| 3 Month Change | 2.45% |
| 1 Year Change | 15.93% |
| 3 Year Change | 71.19% |
| 5 Year Change | 245.99% |
| Change since IPO | 3,247.39% |
Recent News & Updates
Recent updates
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23
Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?
Oct 25Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?
Oct 04Why Abbott India Limited (NSE:ABBOTINDIA) Should Be In Your Dividend Portfolio
Sep 13Abbott India Limited (NSE:ABBOTINDIA) Looks Interesting, And It's About To Pay A Dividend
Aug 23Is Abbott India's (NSE:ABBOTINDIA) 295% Share Price Increase Well Justified?
Aug 17Earnings Tell The Story For Abbott India Limited (NSE:ABBOTINDIA)
Jul 27What You Need To Know About Abbott India Limited's (NSE:ABBOTINDIA) Investor Composition
Jul 06Shareholder Returns
| ABBOTINDIA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.5% | -0.1% | 1.8% |
| 1Y | 15.9% | 55.9% | 46.4% |
Return vs Industry: ABBOTINDIA underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: ABBOTINDIA underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: ABBOTINDIA has not had significant price volatility in the past 3 months.
Volatility Over Time: ABBOTINDIA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1910 | 3,700 | n/a | www.abbott.co.in |
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women’s health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India.
Abbott India Limited Fundamentals Summary
| ABBOTINDIA fundamental statistics | |
|---|---|
| Market cap | ₹545.33b |
| Earnings (TTM) | ₹11.46b |
| Revenue (TTM) | ₹57.53b |
47.6x
P/E Ratio9.5x
P/S RatioIs ABBOTINDIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABBOTINDIA income statement (TTM) | |
|---|---|
| Revenue | ₹57.53b |
| Cost of Revenue | ₹31.86b |
| Gross Profit | ₹25.68b |
| Other Expenses | ₹14.22b |
| Earnings | ₹11.46b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 539.11 |
| Gross Margin | 44.63% |
| Net Profit Margin | 19.91% |
| Debt/Equity Ratio | 2.9% |
How did ABBOTINDIA perform over the long term?
See historical performance and comparison